Medpage Today on MSN6d
Year in Review: Inflammatory Bowel Disease
Notable news about inflammatory bowel disease (IBD) in 2024 included a study evaluating loss of response to tumor necrosis ...
Medscape9d
In IBD Patients, No Increased Risk for MACE Seen for JAK Inhibitors Vs Anti-TNF
Patients with IBD don’t face an increased risk for major adverse cardiovascular events when taking Janus kinase inhibitors ...
WBAL TV Baltimore on MSN3d
Woman's Doctor: Women of child-bearing age need to be vigilant for ulcerative colitis symptoms
The causes of ulcerative colitis aren't quite known, but women of child-bearing age should be especially vigilant for ...
emjreviews.com2d
Review of United European Gastroenterology (UEG) Week 2024
LEADING Austrian health experts gathered at UEG Week 2024 to push forward the implementation of a nationwide, quality-assured ...
MyChesCo on MSN5d
2024 Advances in IBD Conference Showcases New Educational Opportunities and Honors Exceptional Leaders
The 2024 Advances in Inflammatory Diseases (AIBD) conference is set to provide groundbreaking educational opportunities and ...
Crohn’s Disease Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Pipeline, Epidemiology and Companies by DelveInsight
DelveInsight's "Crohn’s Disease Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth ...
Medindia2d
Palatin Announces Completion of Patient Enrollment in Phase 2 Study of Orally Administered Melanocortin Agonist PL8177 in Ulcerative Colitis
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate ...
Medical News Today28d
FDA-approved drug for ulcerative colitis also effective for Crohn's
There is currently no cure for IBD. Medications, surgery, and lifestyle changes can help alleviate symptoms Recently, the drug’s manufacturer, pharmaceutical company Eli Lilly, released the ...